Literature DB >> 30911953

Immune Dysregulation and Disease Pathogenesis due to Activating Mutations in PIK3CD-the Goldilocks' Effect.

Stuart G Tangye1,2, Julia Bier3,4, Anthony Lau3,4, Tina Nguyen3,4, Gulbu Uzel5, Elissa K Deenick3,4.   

Abstract

"This porridge is too hot!" she exclaimed. So, she tasted the porridge from the second bowl. "This porridge is too cold," she said. So, she tasted the last bowl of porridge. "Ahhh, this porridge is just right," she said happily and she ate it all up. While this describes the adventures of Goldilocks in the classic fairytale "The Story of Goldilocks and the Three Bears," it is an ideal analogy for the need for balanced signaling mediated by phosphatidylinositol-3-kinase (PI3K), a key signaling hub in immune cells. Either too little or too much PI3K activity is deleterious, even pathogenic-it needs to be "just right"! This has been elegantly demonstrated by the identification of inborn errors of immunity in key components of the PI3K pathway, and the impact of these mutations on immune regulation. Detailed analyses of patients with germline activating mutations in PIK3CD, as well as the parallel generation of novel murine models of this disease, have shed substantial light on the role of PI3K in lymphocyte development and differentiation, and mechanisms of disease pathogenesis resulting not only from PIK3CD mutations but genetic lesions in other components of the PI3K pathway. Furthermore, by being able to pharmacologically target PI3K, these monogenic conditions have provided opportunities for the implementation of precision medicine as a therapy, as well as to gain further insight into the consequences of modulating the PI3K pathway in clinical settings.

Entities:  

Keywords:  PI3 kinase; activated PI3Kinase delta syndrome; combined immunodeficiency

Year:  2019        PMID: 30911953     DOI: 10.1007/s10875-019-00612-9

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  85 in total

1.  Suppression of phosphatidylinositol 3,4,5-trisphosphate production is a key determinant of B cell anergy.

Authors:  Cecille D Browne; Christopher J Del Nagro; Matthew H Cato; Hart S Dengler; Robert C Rickert
Journal:  Immunity       Date:  2009-11-05       Impact factor: 31.745

2.  Hematopoietic stem cell transplant in patients with activated PI3K delta syndrome.

Authors:  Zohreh Nademi; Mary A Slatter; Christopher C Dvorak; Benedicte Neven; Alain Fischer; Felipe Suarez; Claire Booth; Kanchan Rao; Alexandra Laberko; Julia Rodina; Yves Bertrand; Sylwia Kołtan; Robert Dębski; Terence Flood; Mario Abinun; Andrew R Gennery; Sophie Hambleton; Stephan Ehl; Andrew J Cant
Journal:  J Allergy Clin Immunol       Date:  2016-11-12       Impact factor: 10.793

3.  Mutations in PIK3R1 can lead to APDS2, SHORT syndrome or a combination of the two.

Authors:  M Bravo García-Morato; S García-Miñaúr; J Molina Garicano; F Santos Simarro; L Del Pino Molina; E López-Granados; A Ferreira Cerdán; R Rodríguez Pena
Journal:  Clin Immunol       Date:  2017-03-14       Impact factor: 3.969

4.  Mutations in PIK3CD can cause hyper IgM syndrome (HIGM) associated with increased cancer susceptibility.

Authors:  M C Crank; J K Grossman; S Moir; S Pittaluga; C M Buckner; L Kardava; A Agharahimi; H Meuwissen; J Stoddard; J Niemela; H Kuehn; S D Rosenzweig
Journal:  J Clin Immunol       Date:  2014-03-08       Impact factor: 8.317

5.  Identification of variations in the human phosphoinositide 3-kinase p110delta gene in children with primary B-cell immunodeficiency of unknown aetiology.

Authors:  S-T Jou; Y-H Chien; Y-H Yang; T-C Wang; S-D Shyur; C-C Chou; M-L Chang; D-T Lin; K-H Lin; B-L Chiang
Journal:  Int J Immunogenet       Date:  2006-10       Impact factor: 1.466

6.  Phosphoinositide 3-kinase activity in T cells regulates the magnitude of the germinal center reaction.

Authors:  Julia Rolf; Sarah E Bell; Dorottya Kovesdi; Michelle L Janas; Dalya R Soond; Louise M C Webb; Sara Santinelli; Ted Saunders; Barbara Hebeis; Nigel Killeen; Klaus Okkenhaug; Martin Turner
Journal:  J Immunol       Date:  2010-09-08       Impact factor: 5.422

7.  PIK3R1 mutations cause syndromic insulin resistance with lipoatrophy.

Authors:  Christel Thauvin-Robinet; Martine Auclair; Laurence Duplomb; Martine Caron-Debarle; Magali Avila; Judith St-Onge; Martine Le Merrer; Bernard Le Luyer; Delphine Héron; Michèle Mathieu-Dramard; Pierre Bitoun; Jean-Michel Petit; Sylvie Odent; Jeanne Amiel; Damien Picot; Virginie Carmignac; Julien Thevenon; Patrick Callier; Martine Laville; Yves Reznik; Cédric Fagour; Marie-Laure Nunes; Jacqueline Capeau; Olivier Lascols; Frédéric Huet; Laurence Faivre; Corinne Vigouroux; Jean-Baptiste Rivière
Journal:  Am J Hum Genet       Date:  2013-06-27       Impact factor: 11.025

8.  Hematopoietic stem cell transplantation for progressive combined immunodeficiency and lymphoproliferation in patients with activated phosphatidylinositol-3-OH kinase δ syndrome type 1.

Authors:  Tsubasa Okano; Kohsuke Imai; Yuki Tsujita; Noriko Mitsuiki; Kenichi Yoshida; Chikako Kamae; Kenichi Honma; Kanako Mitsui-Sekinaka; Yujin Sekinaka; Tamaki Kato; Katsuyuki Hanabusa; Eri Endo; Takehiro Takashima; Haruka Hiroki; Tzu-Wen Yeh; Keisuke Tanaka; Masakazu Nagahori; Ikuya Tsuge; Yuki Bando; Fuminori Iwasaki; Yoshiaki Shikama; Masami Inoue; Tomiko Kimoto; Naohiko Moriguchi; Yuki Yuza; Takashi Kaneko; Kyoko Suzuki; Tomoyo Matsubara; Yoshihiro Maruo; Tomoaki Kunitsu; Tomoko Waragai; Hideki Sano; Yuko Hashimoto; Kazuhiro Tasaki; Osamu Suzuki; Toshihiko Shirakawa; Motohiro Kato; Toru Uchiyama; Masataka Ishimura; Tetsuzo Tauchi; Hiroshi Yagasaki; Shiann-Tarng Jou; Hsin-Hui Yu; Hirokazu Kanegane; Sven Kracker; Anne Durandy; Daiei Kojima; Hideki Muramatsu; Taizo Wada; Yuzaburo Inoue; Hidetoshi Takada; Seiji Kojima; Seishi Ogawa; Osamu Ohara; Shigeaki Nonoyama; Tomohiro Morio
Journal:  J Allergy Clin Immunol       Date:  2018-05-18       Impact factor: 10.793

9.  Critical roles of Pten in B cell homeostasis and immunoglobulin class switch recombination.

Authors:  Akira Suzuki; Tsuneyasu Kaisho; Minako Ohishi; Manae Tsukio-Yamaguchi; Takeshi Tsubata; Pandelakis A Koni; Takehiko Sasaki; Tak Wah Mak; Toru Nakano
Journal:  J Exp Med       Date:  2003-03-03       Impact factor: 14.307

Review 10.  Genetic Defects in Phosphoinositide 3-Kinase δ Influence CD8+ T Cell Survival, Differentiation, and Function.

Authors:  Jennifer L Cannons; Silvia Preite; Senta M Kapnick; Gulbu Uzel; Pamela L Schwartzberg
Journal:  Front Immunol       Date:  2018-08-02       Impact factor: 7.561

View more
  14 in total

1.  PIK3IP1 Promotes Extrafollicular Class Switching in T-Dependent Immune Responses.

Authors:  Kristina Ottens; Jalyn Schneider; Lawrence P Kane; Anne B Satterthwaite
Journal:  J Immunol       Date:  2020-09-04       Impact factor: 5.422

2.  Editorial, Journal of Clinical Immunology.

Authors:  Jean-Laurent Casanova; Vincent Bonagura
Journal:  J Clin Immunol       Date:  2019-11       Impact factor: 8.317

3.  PI3K Isoforms in B Cells.

Authors:  Elissa K Deenick; Julia Bier; Anthony Lau
Journal:  Curr Top Microbiol Immunol       Date:  2022       Impact factor: 4.737

Review 4.  Autoimmune Cytopenia as an Early and Initial Presenting Manifestation in Activated PI3 Kinase Delta Syndrome: Case Report and Review.

Authors:  Stephen A Schworer; Olivia L Francis; Steven M Johnson; Benjamin D Smith; Stuart H Gold; Andrew B Smitherman; Eveline Y Wu
Journal:  J Pediatr Hematol Oncol       Date:  2021-11-01       Impact factor: 1.289

Review 5.  Beyond monogenetic rare variants: tackling the low rate of genetic diagnoses in predominantly antibody deficiency.

Authors:  Emily S J Edwards; Julian J Bosco; Samar Ojaimi; Robyn E O'Hehir; Menno C van Zelm
Journal:  Cell Mol Immunol       Date:  2020-08-17       Impact factor: 11.530

6.  Immune Activation Induces Telomeric DNA Damage and Promotes Short-Lived Effector T Cell Differentiation in Chronic HCV Infection.

Authors:  Lam Nhat Nguyen; Lam Ngoc Thao Nguyen; Juan Zhao; Madison Schank; Xindi Dang; Dechao Cao; Sushant Khanal; Bal Krishna Chand Thakuri; Jinyu Zhang; Zeyuan Lu; Xiao Y Wu; Mohamed El Gazzar; Shunbin Ning; Ling Wang; Jonathan P Moorman; Zhi Q Yao
Journal:  Hepatology       Date:  2021-08-25       Impact factor: 17.425

Review 7.  PI3K inhibitors are finally coming of age.

Authors:  Bart Vanhaesebroeck; Matthew W D Perry; Jennifer R Brown; Fabrice André; Klaus Okkenhaug
Journal:  Nat Rev Drug Discov       Date:  2021-06-14       Impact factor: 112.288

Review 8.  Exploring the pathways to chronic lymphocytic leukemia.

Authors:  Freda K Stevenson; Francesco Forconi; Thomas J Kipps
Journal:  Blood       Date:  2021-09-09       Impact factor: 25.476

9.  Short stature and combined immunodeficiency associated with mutations in RGS10.

Authors:  Ivan K Chinn; Zhihui Xie; Eunice C Chan; Bianca M Nagata; Alexey Koval; Wei-Sheng Chen; Fan Zhang; Sundar Ganesan; Diana N Hong; Motoshi Suzuki; Glenn Nardone; Ian N Moore; Vladimir L Katanaev; Andrea E Balazs; Chengyu Liu; James R Lupski; Jordan S Orange; Kirk M Druey
Journal:  Sci Signal       Date:  2021-07-27       Impact factor: 9.517

10.  Human Inborn Errors of Immunity: 2019 Update on the Classification from the International Union of Immunological Societies Expert Committee.

Authors:  Stuart G Tangye; Waleed Al-Herz; Aziz Bousfiha; Talal Chatila; Charlotte Cunningham-Rundles; Amos Etzioni; Jose Luis Franco; Steven M Holland; Christoph Klein; Tomohiro Morio; Hans D Ochs; Eric Oksenhendler; Capucine Picard; Jennifer Puck; Troy R Torgerson; Jean-Laurent Casanova; Kathleen E Sullivan
Journal:  J Clin Immunol       Date:  2020-01-17       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.